Meeting
2014 Gastrointestinal Cancers Symposium
A province-wide retrospective comparison of pathologic response and progression-free survival in locally advanced esophagus cancer patients treated with either cisplatin-5FU (CF) or carboplatin-paclitaxel (CP) concurrent with radiation (XRT) with or without surgery.
Authors
Devin Schellenberg
British Columbia Cancer Agency, Surrey, BC, Canada
Devin Schellenberg , Renata Peixoto , Andrea Lee , Howard John Lim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 107)
DOI
10.1200/jco.2014.32.3_suppl.107
Abstract #
107
Poster Bd #
D11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2018 ASCO Annual Meeting
Induction chemoradiotherapy for esophageal cancer: Comparing CROSS regimen with cisplatin/5-FU.
First Author: Abraham Geller
Poster
2018 Gastrointestinal Cancers Symposium
Nonoperative management of locally advanced esophageal and junctional (GEJ) cancers: The University of Rochester experience.
First Author: Rachel Julie David
Poster
2017 ASCO Annual Meeting
Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer.
First Author: Hao-Wen Sim